These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6572492

  • 1. Biological activity of 24,24-difluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone in inducing differentiation of human myeloid leukemia cells.
    Shiina Y, Abe E, Miyaura C, Tanaka H, Yamada S, Ohmori M, Nakayama K, Takayama H, Matsunaga I, Nishii Y, DeLuca HF, Suda T.
    Arch Biochem Biophys; 1983 Jan; 220(1):90-4. PubMed ID: 6572492
    [Abstract] [Full Text] [Related]

  • 2. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
    Inaba M, Okuno S, Nishizawa Y, Yukioka K, Otani S, Matsui-Yuasa I, Morisawa S, DeLuca HF, Morii H.
    Arch Biochem Biophys; 1987 Nov 01; 258(2):421-5. PubMed ID: 2823715
    [Abstract] [Full Text] [Related]

  • 3. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3.
    Kuribayashi T, Tanaka H, Abe E, Suda T.
    Endocrinology; 1983 Dec 01; 113(6):1992-8. PubMed ID: 6315339
    [Abstract] [Full Text] [Related]

  • 4. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
    Wilhelm F, Mayer E, Norman AW.
    Arch Biochem Biophys; 1984 Sep 01; 233(2):322-9. PubMed ID: 6091549
    [Abstract] [Full Text] [Related]

  • 5. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
    Koizumi T, Nakao Y, Ishizuka S, Oshida J, Hara N, Ikekawa N, Fijita T.
    Arch Biochem Biophys; 1990 Feb 01; 276(2):310-6. PubMed ID: 2407190
    [Abstract] [Full Text] [Related]

  • 6. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW, Zhou JY, Henry HL, Uskokovic MR, Koeffler HP.
    Cancer Res; 1990 Nov 01; 50(21):6857-64. PubMed ID: 2208153
    [Abstract] [Full Text] [Related]

  • 7. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
    Honda A, Nakashima N, Mori Y, Katsumata T, Ishizuka S.
    J Steroid Biochem Mol Biol; 1992 Jan 01; 41(1):109-12. PubMed ID: 1310414
    [Abstract] [Full Text] [Related]

  • 8. Calcium regulating activity of 24a-homo-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3.
    Harada M, Miyahara T, Miyata M, Komiyama H, Sugure A, Ikemoto Y, Kondo S, Takamura T, Higuchi S, Otomo S.
    Calcif Tissue Int; 1993 Nov 01; 53(5):318-23. PubMed ID: 8287319
    [Abstract] [Full Text] [Related]

  • 9. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites in vivo and in vitro.
    Ishizuka S, Sumitani K, Hiura K, Kawata T, Okawa M, Hakeda Y, Kumegawa M.
    Endocrinology; 1990 Aug 01; 127(2):695-701. PubMed ID: 2373050
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ, Lee YY, Pakkala S, de Vos S, Elstner E, Norman AW, Green J, Uskokovic M, Koeffler HP.
    Leuk Res; 1994 Jun 01; 18(6):453-63. PubMed ID: 8207963
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
    Munker R, Kobayashi T, Elstner E, Norman AW, Uskokovic M, Zhang W, Andreeff M, Koeffler HP.
    Blood; 1996 Sep 15; 88(6):2201-9. PubMed ID: 8822940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.